Astellas Pharma Stock Forecast

Hold candidate since Jun 18, 2026

The Astellas Pharma, Inc. stock price gained 3.04% on the last trading day (Thursday, 18th Jun 2026), rising from $13.40 to $13.81. During the last trading day the stock fluctuated 5.74% from a day low at $13.81 to a day high of $14.60. The price has risen in 4 of the last 10 days but is still down by -4.11% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 812 more shares were traded than the day before. In total, 812 shares were bought and sold for approximately $11.21 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.33% during the next 3 months and, with a 90% probability hold a price between $9.51 and $11.98 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ALPMF Signals & Forecast

There are mixed signals in the stock today. The Astellas Pharma, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $14.33. On a fall, the stock will find some support from the short-term average at $13.76. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, May 12, 2026, and so far it has fallen -12.33%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Astellas Pharma, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Astellas Pharma, Inc. stock

Astellas Pharma, Inc. finds support from accumulated volume at $13.75 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.792 between high and low, or 5.74%. For the last week, the stock has had daily average volatility of 3.53%.

Our recommended stop-loss: $13.03 (-5.66%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 26 days ago.)

Trading Expectations (ALPMF) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Astellas Pharma, Inc. to open at $14.07, and during the day (based on 14 day Average True Range), to move between $13.33 and $14.28, which gives a possible trading interval of +/-$0.95 (+/-7.10%) up or down from last closing price. If Astellas Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 7.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $13.75 (0.42%) than the resistance at $14.26 (3.27%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Dividend Warning For ALPMF

Dividend coming up for ALPMF: Ex-dividend date (Tuesday 29th September, 2026) is 99 days away. The dividend is $0.200.

Is Astellas Pharma, Inc. stock A Buy?

Astellas Pharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $14.07 ( 1.91%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk